Seoane-Viaño, Iria;
Pérez-Ramos, Tania;
Liu, Jiaqi;
Januskaite, Patricija;
Guerra-Baamonde, Elena;
González-Ramírez, Jorge;
Vázquez-Caruncho, Manuel;
... Goyanes, Alvaro; + view all
(2024)
Visualizing disintegration of 3D printed tablets in humans using MRI and comparison with in vitro data.
Journal of Controlled Release
, 365
pp. 348-357.
10.1016/j.jconrel.2023.11.022.
Preview |
Text
1-s2.0-S0168365923007393-main.pdf - Published Version Download (6MB) | Preview |
Abstract
Three-dimensional (3D) printing is revolutionising the way that medicines are manufactured today, paving the way towards more personalised medicine. However, there is limited in vivo data on 3D printed dosage forms, and no studies to date have been performed investigating the intestinal behaviour of these drug products in humans, hindering the complete translation of 3D printed medications into clinical practice. Furthermore, it is unknown whether conventional in vitro release tests can accurately predict the in vivo performance of 3D printed formulations in humans. In this study, selective laser sintering (SLS) 3D printing technology has been used to produce two placebo torus-shaped tablets (printlets) using different laser scanning speeds. The printlets were administered to 6 human volunteers, and in vivo disintegration times were assessed using magnetic resonance imaging (MRI). In vitro disintegration tests were performed using a standard USP disintegration apparatus, as well as an alternative method based on the use of reduced media volume and minimal agitation. Printlets fabricated at a laser scanning speed of 90 mm/s exhibited an average in vitro disintegration time of 7.2 ± 1 min (measured using the USP apparatus) and 25.5 ± 4.1 min (measured using the alternative method). In contrast, printlets manufactured at a higher laser scanning speed of 130 mm/s had an in vitro disintegration time of 2.8 ± 0.8 min (USP apparatus) and 18.8 ± 1.9 min (alternative method). When tested in humans, printlets fabricated at a laser scanning speed of 90 mm/s showed an average disintegration time of 17.3 ± 7.2 min, while those manufactured at a laser scanning speed of 130 mm/s exhibited a shorter disintegration time of 12.7 ± 6.8 min. Although the disintegration times obtained using the alternative method more closely resembled those obtained in vivo, no clear correlation was observed between the in vitro and in vivo disintegration times, highlighting the need to develop better in vitro methodology for 3D printed drug products.
| Type: | Article |
|---|---|
| Title: | Visualizing disintegration of 3D printed tablets in humans using MRI and comparison with in vitro data |
| Location: | Netherlands |
| Open access status: | An open access version is available from UCL Discovery |
| DOI: | 10.1016/j.jconrel.2023.11.022 |
| Publisher version: | https://doi.org/10.1016/j.jconrel.2023.11.022 |
| Language: | English |
| Additional information: | Copyright © 2023 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/). |
| Keywords: | Selective laser sintering 3D printing of formulations; Gastrointestinal disintegration of drug delivery systems and products; In vivo in vitro correlations; Gastric emptying and intestinal transit; Digital health and industry 4.0; Additive manufacturing of personalized medicines |
| UCL classification: | UCL UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Life Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Life Sciences > UCL School of Pharmacy UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Life Sciences > UCL School of Pharmacy > Pharmaceutics |
| URI: | https://discovery.ucl.ac.uk/id/eprint/10182781 |
Archive Staff Only
 |
View Item |
